Cas 1007879-75-5,(R)-2-(dimethylamino)-2-(2-chlorophenyl)acetic acid

1007879-75-5

Post Buying Request

Basic information

Product Name: (R)-2-(dimethylamino)-2-(2-chlorophenyl)acetic acid
Synonyms: (R)-2-(dimethylamino)-2-(2-chlorophenyl)acetic acid
CAS NO:1007879-75-5
Molecular Formula:
Molecular Weight: 213.664
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (R)-2-(dimethylamino)-2-(2-chlorophenyl)acetic acid(CAS DataBase Reference)
NIST Chemistry Reference: (R)-2-(dimethylamino)-2-(2-chlorophenyl)acetic acid(1007879-75-5)
EPA Substance Registry System: (R)-2-(dimethylamino)-2-(2-chlorophenyl)acetic acid(1007879-75-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1007879-75-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1007879-75-5 Suppliers

Recommended suppliers

1007879-75-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1007879-75-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,8,7 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1007879-75:
(9*1)+(8*0)+(7*0)+(6*7)+(5*8)+(4*7)+(3*9)+(2*7)+(1*5)=165
165 % 10 = 5
So 1007879-75-5 is a valid CAS Registry Number.

1007879-75-5Upstream product

1007879-75-5Downstream Products

1007879-76-6 (R)-2-(dimethylamino)-2-(2-chlorophenyl)acetic acid trifluoroacetate

1007879-75-5Relevant academic research and scientific papers

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 59, (2012/02/15)

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

BI-1H-BENZIMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 210, (2010/04/03)

The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Hepatitis C Virus Inhibitors

-

Page/Page column 39, (2010/10/19)

This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

Hepatitis C Virus Inhibitors

-

, (2009/08/18)

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 66, (2009/10/09)

The present disclosure relates to (4-4' -diimidazolyl) biphenyls compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Hepatitis C Virus Inhibitors

-

Page/Page column 44-45, (2008/06/13)

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1007879-75-5